2024

1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

   Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

3. Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis

   Medicina Clinica, Vol. 163, Núm. 6, pp. 269-274

4. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

5. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

6. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

7. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

   Thrombosis Research, Vol. 235, pp. 22-31

8. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

9. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

   Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

10. Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

    Hamostaseologie, Vol. 44, Núm. 3, pp. 182-192

11. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

12. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

13. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

14. Pulmonary embolism: Put the sPESI into practice

    European Journal of Internal Medicine

15. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

16. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

17. Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

    Thrombosis Research, Vol. 233, pp. 18-24

18. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry

    Thrombosis Research, Vol. 236, pp. 88-96

19. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

20. Time to Resolution of Right Ventricle Dysfunction in Patients With Acute Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 448-450